The European League Against Rheumatism (EULAR)/ACR 2019 classification criteria for SLE requires a positive antinuclear antibody (ANA) as an obligatory entry criterion along with additive criteria in clinical and immunological domains. This evidence concerns the gene BTG3 and systemic lupus erythematosus.